1. Home
  2. AVXL vs KOPN Comparison

AVXL vs KOPN Comparison

Compare AVXL & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$4.37

Market Cap

397.6M

Sector

Health Care

ML Signal

HOLD

Logo Kopin Corporation

KOPN

Kopin Corporation

HOLD

Current Price

$2.70

Market Cap

424.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVXL
KOPN
Founded
2004
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
397.6M
424.9M
IPO Year
N/A
1992

Fundamental Metrics

Financial Performance
Metric
AVXL
KOPN
Price
$4.37
$2.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$22.00
$4.25
AVG Volume (30 Days)
4.6M
3.4M
Earning Date
11-25-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$45,602,295.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$43.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.02
52 Week Low
$2.86
$0.71
52 Week High
$14.44
$4.16

Technical Indicators

Market Signals
Indicator
AVXL
KOPN
Relative Strength Index (RSI) 40.02 51.88
Support Level $3.62 $2.26
Resistance Level $4.84 $2.44
Average True Range (ATR) 0.42 0.17
MACD 0.23 0.06
Stochastic Oscillator 74.53 84.50

Price Performance

Historical Comparison
AVXL
KOPN

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

Share on Social Networks: